Factors predicting survival after post‐transplant hepatocellular carcinoma recurrence
Open Access
- 19 June 2012
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 20 (3), 342-347
- https://doi.org/10.1007/s00534-012-0528-4
Abstract
Background Although factors associated with an increased risk of recurrence after liver transplantation for hepatocellular carcinoma (HCC) have been extensively studied, the history of patients with a post‐transplant recurrence is poorly known. Methods Patients experiencing a post‐transplant HCC recurrence from 1996 to 2011 in two transplant programs were included. Demographic, transplant, and post‐recurrence variables were assessed. Results Thirty patients experienced an HCC recurrence—22 men and 8 women with a mean age of 55 ± 6 years. Sixteen (53 %) were outside the Milan criteria at the time of transplantation. Most recurrences (60 %) appeared within the first 18 months after transplantation, ranging between 1.7 and 109 months (median 14.2 months). Mean post‐recurrence survival was 33 ± 31 months. On univariate analysis, total tumor volume (TTV;p = 0.047), microvascular invasion (p = 0.011), and time from transplant to recurrence (p = 0.001) predicted post‐recurrence survival. On multivariate analysis, both time from transplant to recurrence (p = 0.001) and history of rejection (p = 0.043), but not the location of the recurrence or the type of recurrence treatment, predicted post‐recurrence survival. Conclusion This study suggests that patients with early post‐transplant HCC recurrence have worse outcomes. Those with a history of graft rejection have better survivals, possibly due to more active anti‐cancer immunity.Keywords
This publication has 23 references indexed in Scilit:
- Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variablesEuropean Journal of Surgical Oncology, 2010
- Management of Hepatocellular Carcinoma Recurrence After Liver TransplantationTransplantation Proceedings, 2010
- Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinomaLiver Transplantation, 2010
- Impact of smoking on patients with stage III colon cancerCancer, 2010
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinomaHepatology, 2009
- Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients databaseHepatology, 2008
- Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2008
- Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patientsWorld Journal of Gastroenterology, 2006
- Pattern and management of recurrent hepatocellular carcinoma after liver transplantationJournal of Hepato-Biliary-Pancreatic Surgery, 1998
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996